| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/10/2011 | US20110033490 Compositions and methods for diagnosing and/or treating influenza infection |
| 02/10/2011 | US20110033486 Gene expression markers for crohn's disease |
| 02/10/2011 | US20110033482 Her3 as a determinant for the prognosis of melanoma |
| 02/10/2011 | US20110033481 Prospective identification and characterization of breast cancer stem cells |
| 02/10/2011 | US20110033477 Method for diagnosing and treating chronic psychiatric illnesses and markers and targets for such methods |
| 02/10/2011 | US20110033476 Compositions and methods for the therapy and diagnosis of influenza |
| 02/10/2011 | US20110033473 Anti influenza antibodies and uses thereof |
| 02/10/2011 | US20110033470 Human G-Protein Coupled Receptor |
| 02/10/2011 | US20110033466 Human transcriptomes |
| 02/10/2011 | US20110033462 Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (jev) and their use |
| 02/10/2011 | US20110033454 Methods For Treating Diseases Using Antibodies to Aminophospolipids |
| 02/10/2011 | US20110033448 Inhibitors of LL-37 Mediated Immune Reactivity to Self Nucleic Acids |
| 02/10/2011 | US20110033444 Genetic variants in a hypertension susceptibility gene Stk39 and uses thereof |
| 02/10/2011 | US20110033439 Targeted antimicrobials and related compositions, methods and systems |
| 02/10/2011 | US20110033438 Method and pharmacological composition for the diagnosis and treatment of male |
| 02/10/2011 | US20110033390 Mr imaging agent or medium compressing hyperpolarised 13c alanine and methods of imaging wherein such an imaging medium is used |
| 02/10/2011 | US20110033387 Method of determination of pdh activity and imaging media for use in said method |
| 02/10/2011 | US20110031133 Biosensor Having Improved Hematocrit and Oxygen Biases |
| 02/10/2011 | US20110030926 Cooling systems using coatings with surface energy gradient |
| 02/10/2011 | DE202010014877U1 Testsystem zur Bestimmung der Peroxydase-Aktivität in biologischen Flüssigkeiten Test system for the determination of peroxidase activity in biological fluids |
| 02/10/2011 | DE102007013107B4 Verfahren zur Bestimmung des Geschlechts von Vögeln A method for determining the sex of birds |
| 02/10/2011 | CA2772326A1 Pairing processes for preparing alloreactive cytotoxic t cells |
| 02/10/2011 | CA2769756A1 Method for determining the presence and concentration of analytes using a nucleic acid ligand and rare earth element |
| 02/10/2011 | CA2769651A1 Improved plants, microbes, and organisms |
| 02/10/2011 | CA2769333A1 Enterococcus and fecal bacteroides for rapid water quality assessment |
| 02/10/2011 | CA2769320A1 Cell concentration, capture and lysis devices and methods of use thereof |
| 02/10/2011 | CA2769262A1 Methods and compositions for treating trinucleotide repeat disorders |
| 02/10/2011 | CA2769230A1 Use of microrna for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells |
| 02/10/2011 | CA2769043A1 Improved detection of bacterial (mollicutes) contamination |
| 02/10/2011 | CA2766523A1 Responsiveness to angiogenesis inhibitors |
| 02/09/2011 | EP2282205A1 Underfill detection method for an electrochemical biosensor |
| 02/09/2011 | EP2281904A1 In vitro method for predicting whether a compound is genotoxic in vivo. |
| 02/09/2011 | EP2281903A1 Cancer marker, method for evaluation of cancer by using the cancer marker, and evaluation reagent |
| 02/09/2011 | EP2281902A1 Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders |
| 02/09/2011 | EP2281900A1 Fructosyl peptidyl oxidase and sensor for assaying a glycated protein |
| 02/09/2011 | EP2281889A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 02/09/2011 | EP2281888A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 02/09/2011 | EP2281883A1 Method for determination of dna methylation |
| 02/09/2011 | EP2281882A1 Nucleic acid containing chimeric gene derived from hepatitis type-c virus |
| 02/09/2011 | EP2281879A1 Method and apparatus for selectively targeting specific cells within a cell population |
| 02/09/2011 | EP2281841A2 Biomarkers for pre-selection of patients for anti-IGF1R therapy |
| 02/09/2011 | EP2281835A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281834A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281833A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281798A1 Anthraquinone quencher dyes, their methods of preparation and use |
| 02/09/2011 | EP2281447A2 Corn event MIR604 |
| 02/09/2011 | EP2281199A1 Detecting infection in reduced pressure wound treatment |
| 02/09/2011 | EP2281070A2 Method for detecting chikungunya virus |
| 02/09/2011 | EP2281069A2 Methods for identifying subjects with an increased likelihood of responding to dpp-iv inhibitors |
| 02/09/2011 | EP2281068A1 Glutamine biomarkers for depression |
| 02/09/2011 | EP2281067A1 Gaba biomarkers for depression |
| 02/09/2011 | EP2281066A2 Biomarkers for depression |
| 02/09/2011 | EP2281065A2 Method for evaluating and comparing immunorepertoires |
| 02/09/2011 | EP2281064A1 Method for labelling a product using a plurality of polynucleotides, method for identifying the labelling and labelled product |
| 02/09/2011 | EP2281063A1 A method for predicting a clinical response of a patient suffering from or at risk of developing cancer towards a given mode of treatment |
| 02/09/2011 | EP2281062A2 Geometric patterns and lipid bilayers for dna molecule organization and uses thereof |
| 02/09/2011 | EP2281061A1 Diagnostic methods for determining prognosis of non-small cell lung cancer |
| 02/09/2011 | EP2281060A1 Androgenetic alopecia |
| 02/09/2011 | EP2281059A2 Method and apparatus for determining a probability of colorectal cancer in a subject |
| 02/09/2011 | EP2281058A1 Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders |
| 02/09/2011 | EP2281056A1 Method for enzymatic assessment of the toxicity of environmental aqueous matrices |
| 02/09/2011 | EP2281055A1 Methods for detecting organisms and enzymatic reactions using raman spectroscopy |
| 02/09/2011 | EP2281046A2 LUCIFERASE BIOSENSORS FOR cAMP |
| 02/09/2011 | EP2281045A1 Therapy delivery and monitoring using a gene of interest-reporter fusion protein and optical imaging |
| 02/09/2011 | EP2077333B1 Method for quantification of cholesterol in small dense low-density lipoprotein |
| 02/09/2011 | EP2008098B1 Biosensor having nano wire for detecting food additive mono sodium glutamate and manufacturing method thereof |
| 02/09/2011 | EP1931796B1 Detection of salmonella lactose+ |
| 02/09/2011 | EP1907544B1 Membrane-translocating peptides |
| 02/09/2011 | EP1748845B1 Devices and methods for collection, storage and transportation of biological specimens |
| 02/09/2011 | EP1700126B1 Staphylococcus detection |
| 02/09/2011 | EP1699936B1 Universal amplification of fragmented rna |
| 02/09/2011 | EP1673472B1 Use of genetic polymorphisms to predict drug-induced hepatotoxicity |
| 02/09/2011 | EP1636561B1 Combinatorial protein library screening by periplasmic expression |
| 02/09/2011 | EP1577390B1 Human cancer-related genes, the products encoded thereby and applications thereof |
| 02/09/2011 | EP1504098B2 A method for in vitro molecular evolution of protein function |
| 02/09/2011 | EP1354060B1 5t4 rna in plasma and serum as a marker for neoplastic disease |
| 02/09/2011 | EP1311680B1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor |
| 02/09/2011 | EP1280898B1 Modified es cells and es cell-specific gene |
| 02/09/2011 | EP1100929B1 Identification and functional characterization of a novel ribosomal s6 protein kinase |
| 02/09/2011 | EP1011686B9 Modulation of human mast cell activation |
| 02/09/2011 | EP0986577B1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 02/09/2011 | EP0668777B2 Prostate-specific membrane antigen |
| 02/09/2011 | CN1969046B Peptide substrates recognisable by a botulinum toxin A, BoNT/A and the use thereof |
| 02/09/2011 | CN101971178A Determining a nucleic acid sequence imbalance |
| 02/09/2011 | CN101971033A Biomarker combinations for colorectal cancer |
| 02/09/2011 | CN101971032A Method for the real-time detection of microorganisms in a liquid culture medium by agglutination |
| 02/09/2011 | CN101970996A Sers-based, single step, real-time detection of protein kinase and/or phosphatase activity |
| 02/09/2011 | CN101970693A Microarray and method of designing negative control probes |
| 02/09/2011 | CN101970692A Lung cancer detecting method using lung cancer specific methylation marker genes |
| 02/09/2011 | CN101970691A A human non-antibody peptide or protein phage library |
| 02/09/2011 | CN101970690A A method of detecting cryptosporidium |
| 02/09/2011 | CN101970689A Gene expression markers for inflammatory bowel disease |
| 02/09/2011 | CN101970688A Methods of using genetic markers and related epistatic interactions |
| 02/09/2011 | CN101970687A Self-assembling micelle-like nanoparticles for systemic gene delivery |
| 02/09/2011 | CN101970686A Methods and applications for target quantification |
| 02/09/2011 | CN101970685A Compositions and methods for diagnosing, treating, and preventing prostate conditions |
| 02/09/2011 | CN101970684A Multiple coagulation test cartridge and method of using same |
| 02/09/2011 | CN101970683A Method for real-time detection of microorganisms in a liquid culture medium using cellular lysis |
| 02/09/2011 | CN101970682A Method for detecting and/or identifying clostridium difficile |
| 02/09/2011 | CN101970681A Living cell judging method for cell observation, image processing program for cell observation, and image processing device |